Netherlands

This is the next step in Trustmoore’s growth journey. By bringing AssetCare’s platform into the Trustmoore Group, they add the technology and fund administration depth to serve their clients better across our jurisdictions. AssetCare will continue to operate under its own brand. Founders Bram Schrijver, Tom Straver and Sam Zwaan remain closely involved, keeping things running smoothly for clients and colleagues.

Osborne Clarke - Netherlands has assisted Sportway Media Group, a Swedish world leading AI-automated sports production company, on its acquisition, together with Broadcast Solutions, a German leading system integrator and provider of innovative solutions for the broadcast media industry, of Studio Automated. The acquisition of Studio Automated, a Dutch based leading AI technology provider for automated and remote live sports production, allows Sportway and Broadcast Solutions to take a significant step toward building one of the world’s most advanced and scalable platforms for live sports production, combining AI-driven technology, software-defined workflows, premium broadcast hardware, and global operational expertise.

Osborne Clarke - Netherlands has advised Myosotis Investments BV as lead investor on the €13 million Series A financing of PamDx, an innovative Dutch CRO specialising in biomarker research and in‑vitro diagnostic services. The round, which also included investment from the EIC - European Innovation Council Fund and existing shareholder, marks an important milestone in the company’s transition from breakthrough innovator to commercial‑stage diagnostics provider. The funding will accelerate the clinical programmes and commercialisation of PamDx’s proprietary iOpener® platform, a ground-breaking new blood test designed for rapid measurement of protein kinases in cancer patients to optimize the use of immunotherapy. Osborne Clarke - Netherlands is pleased to support Myosotis Investments on this transaction, after recently advising them on investments in Scinus Cell Expansion B.V. and Cyclomics. The Osborne Clarke core deal team consisted of M&A/ Venture Capital Partner Herke Van Hulst and associates Angela Saldanha and Saliha El Morabit with support from Notarial Senior Associate Kristianne Voorn. Osborne Clarke has a market-leading international venture capital practice and is widely recognised as a leading European law firm for companies operating in the life science and healthcare sector. Its sector team has a strong track record of providing highly sophisticated advice to investors and biotech clients on cutting-edge issues, across multiple service lines. They work with blue chip venture capital firms, big pharma and medical device companies in the market.

Rvados is an established name in the Dutch IT landscape, supporting organisations with reliable and scalable managed services. Reliance, with the support of Böschen IT Group B.V., is strengthening its position through Rvados as a leading managed services provider. Osborne Clarke - Netherlands team advising on this transaction was led by Corporate M&A Partner Geoffrey Beurskens, with support from Nick Staes and tax support from Job van der Pol and Sjoerd Waagmeester.